Company: CNTB
Filing Date: 2025-06-10
Form Type: F-3
Source: 0001193125-25-138482
Chunk: 0

Company: Connect Biopharma Holdings Ltd
Filing Date: 2025-06-10
Form: F-3
Chunk 0
---
As filed with the Securities and Exchange Commission on June 10, 2025 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CONNECT BIOPHARMA HOLDINGS LIMITED (Exact name of Registrant as specified in its charter) Not Applicable (Translation of Registrant’s name into English)

| Cayman Islands                  |     | Not Applicable     |
| (State or other jurisdiction of 
 incorporation or organization)  |     | -IRS Employer      
 Identification No. |

3580 Carmel Mountain Road, Suite 200 San Diego, California 92130 Tel: +1 858 727 1040 (Address and telephone number of Registrant’s principal executive offices) Connect Biopharm LLC 3580 Carmel Mountain Road, Suite 200 San Diego, California 92130 Tel: +1 858 727 1040 (Name, address, and telephone number of agent for service) With copies to: Michael E. Sullivan, Esq. Latham & Watkins LLP 12670 High Bluff Drive San Diego, California 92130 Tel: +1 858 523 5400 Jeff Cohn, Esq. General Counsel and Corporate Secretary Connect Biopharma Holdings Limited 3580 Carmel Mountain Road, Suite 200 San Diego, California 92130 Tel: +1 858 727 1040 Approximate date of commencement of proposed sale to the public:From time to time after the effective date of this Registration Statement. If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. ☐ If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box. ☒ If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐ If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐